PharmaCorp Rx Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	25.89	12.89	2.24	2.73	0.98
Cash & Short-Term Investments	25.89	12.89	2.24	2.73	0.98
Cash Growth	100.87%	474.84%	-17.99%	178.91%	-
Receivables	1.22	0.33	-	-	-
Inventory	2.71	1.31	-	-	-
Prepaid Expenses	0.08	0.05	-	-	-
Other Current Assets	-	-	0.08	-	0.02
Total Current Assets	29.89	14.57	2.32	2.73	1
Property, Plant & Equipment	5.48	4.02	-	-	-
Goodwill	18.6	11.48	-	-	-
Other Intangible Assets	11.6	5.13	-	-	-
Total Assets	65.57	35.21	2.32	2.73	1
Accounts Payable	5.2	1.54	0.05	0.02	0.03
Current Portion of Long-Term Debt	0.39	0.08	-	-	-
Current Portion of Leases	0.15	0.07	-	-	-
Current Income Taxes Payable	0.06	0.01	-	-	-
Total Current Liabilities	5.81	1.7	0.05	0.02	0.03
Long-Term Debt	3.09	0.32	-	-	-
Long-Term Leases	0.91	0.49	-	-	-
Long-Term Deferred Tax Liabilities	3.49	2.14	-	-	-
Total Liabilities	13.3	4.64	0.05	0.02	0.03
Common Stock	50.95	31.7	2.8	2.74	1
Additional Paid-In Capital	2.01	0.67	0.49	0.52	-
Retained Earnings	-3.14	-2.03	-1.01	-0.54	-0.03
Comprehensive Income & Other	2.11	-	-	-	-
Total Common Equity	51.92	30.34	2.27	2.72	0.97
Minority Interest	0.35	0.22	-	-	-
Shareholders' Equity	52.27	30.57	2.27	2.72	0.97
Total Liabilities & Equity	65.57	35.21	2.32	2.73	1
Total Debt	4.55	0.95	-	-	-
Net Cash (Debt)	21.34	11.93	2.24	2.73	0.98
Net Cash Growth	78.82%	432.33%	-17.99%	178.91%	-
Net Cash Per Share	0.17	0.15	0.11	0.14	0.06
Filing Date Shares Outstanding	174.08	117.3	20.28	20	16.17
Total Common Shares Outstanding	174.08	117.3	20.28	20	16.17
Working Capital	24.08	12.88	2.27	2.72	0.97
Book Value Per Share	0.30	0.26	0.11	0.14	0.06
Tangible Book Value	21.72	13.73	2.27	2.72	0.97
Tangible Book Value Per Share	0.12	0.12	0.11	0.14	0.06
Land	0.36	0.25	-	-	-
Buildings	3.7	2.85	-	-	-
Machinery	0.29	0.13	-	-	-
Leasehold Improvements	0.31	0.31	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.